This week on Pharmacy Times, there are a number of hot topics that we will be posting throughout the week, including:
- An exclusive podcast interview with Russell Procopio, executive vice president of Long-Term Care Pharmacy, where we will be discussing a recent study regarding long-term care outcomes and cost.
- A video interview with Brian Nightengale, president of Good Neighbor Pharmacy, on the value of diversifying a pharmacy’s business through meaningful health and wellness services.
- On Wednesday, Pharmacy Times will feature a clinical overview of ubrogepant (Ubrelvy, Allergan), which is indicated to treat acute migraines with or without aura in adults. Ubrogepant works as a calcitonin gene-related peptide receptor antagonist. CGRP is protein known to be released during migraine attacks, and Ubrogepant reduces CGRP activity by preventing it from binding to its receptors. The article will provide a review of clinical trials, contraindications, warnings, and precautions, as well as counseling information for pharmacists.